Specify a stock or a cryptocurrency in the search bar to get a summary
Nexeon Medsystems Inc
NXNNNexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas. Address: 1910 Pacific Avenue, Dallas, TX, United States, 75201
Analytics
WallStreet Target Price
7.25 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures NXNN
Dividend Analytics NXNN
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NXNN
Stock Valuation NXNN
Financials NXNN
Results | 2019 | Dynamics |